Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ovarian Neoplasms

Free Subscription 18.02.2019 1 Am J Obstet Gynecol 1 Ann Oncol 1 Gynecol Oncol 1 Hum Pathol 1 Int J Gynaecol Obstet 1 J Natl Cancer Inst 1 Oncogene

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Obstet Gynecol

1. CHAM S, Chen L, St Clair CM, Hou JY, et al
   Development and Validation of a Risk-Calculator for Adverse Perioperative Outcomes for Women with Ovarian Cancer.
   Am J Obstet Gynecol. 2019 Feb 13. pii: S0002-9378(19)30360.
   PubMed     Text format     Abstract available
   
   

   
   Ann Oncol

2. LIU JF, Barry WT, Birrer M, Lee JM, et al
   Overall survival and updated progression-free survival outcomes in a randomized phase 2 study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer.
   Ann Oncol. 2019 Feb 7. pii: 5308594. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Gynecol Oncol

3. NAUMANN RW, Coleman RL, Brown J, Moore KN, et al
   Phase III trials in ovarian cancer: The evolving landscape of front line therapy.
   Gynecol Oncol. 2019 Feb 12. pii: S0090-8258(19)30113.
   PubMed     Text format     Abstract available
   
   

   
   Hum Pathol

4. ROY M, Connor J, Al-Niaimi A, Rose SL, et al
   Aldehyde dehydrogenase 1A1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma.
   Hum Pathol. 2018;73:1-6.
   PubMed     Text format     Abstract available
   
   

   
   Int J Gynaecol Obstet

5. LEE DY, Kim HJ, Lee JY, Choi D, et al
   Usefulness of repeat pelvic ultrasonography before surgery for benign ovarian mass.
   Int J Gynaecol Obstet. 2018 Nov 8. doi: 10.1002/ijgo.12708.
   PubMed     Text format     Abstract available
   
   

   
   J Natl Cancer Inst

6. DIXON-SUEN SC, Webb PM, Wilson LF, Tuesley K, et al
   The Association between hysterectomy and ovarian cancer risk: A population-based record-linkage study.
   J Natl Cancer Inst. 2019 Feb 11. pii: 5308404. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Oncogene

7. JOHN B, Naczki C, Patel C, Ghoneum A, et al
   Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC.
   Oncogene. 2019 Feb 14. pii: 10.1038/s41388-019-0728.
   PubMed     Text format     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: